INSM - Insmed announces pricing of $650M public offering
2024-05-30 14:50:45 ET
More on Insmed
- Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)
- Insmed, Inc. (INSM) Q1 2024 Earnings Call Transcript
- Insmed intends to raise $500M via equity offering
- Insmed surges on late-stage win for lung disease therapy (update)
- Seeking Alpha’s Quant Rating on Insmed